Atea Pharmaceuticals Market Sentiment

Market sentiment signals for Atea Pharmaceuticals (AVIR): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus— Outperform

Short Interest▼ 12.7% short float

Options Flow— N/A

Insider Activity— N/A

Analyst Consensus

Outperform

2 analysts

Options Flow (P/C)

—

Avg Consensus PT

+93.6%

Highest Price Target

$10

+127.8%

Evercore ISI Group

Lowest Price Target

+59.5%

Morgan Stanley

Short Interest

12.7%

Rising — Bearish

Insider Activity (30d)

—

Short Interest — % of Float

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Aug 13, 2026	Morgan Stanley	Matthew Harrison—	+59.5%	$6 → $7	Maintained	Equal-Weight
Mar 9, 2026	Evercore ISI Group	Jonathan Miller—	+127.8%	$6 → $10	Maintained	Outperform
Apr 11, 2025	Morgan Stanley	Matthew Harrison—	+36.7%	$6 → $6	Maintained	Equal-Weight
Aug 13, 2024	Morgan Stanley	Matthew Harrison—	+56.7%	$2 → $7	Upgrade	Underweight→Equal-Weight